ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA)

CUSIP: 29251M106

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 7 signals
Share change
+647,195
Put/Call ratio
52%
SEC-reported price per share
$14.58
Number of holders
120
Value change
+$9,944,173
Number of buys
58
Open additional details 1 more signal available
Number of sells
55
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
29,057,686

Security key

29251M106

Report period

Q2 2026

Institutions

120

Top holders

10

Ownership snapshot

Top reported holders of ENTA - ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Janus Henderson Group Ltd.
Disclosed value leader
Janus Henderson Group Ltd.
Comparable rows
15/15
Latest evidence
31 Mar 2026
13F 13D/G 3/4/5 Lead comparable stake: 12% 13D/G row: Janus Henderson Group Ltd. Showing 1-6 of 15 holder rows.

Quick read

Janus Henderson Group Ltd. leads the comparable SEC ownership view at 12%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Janus Henderson Group Ltd.'s linked filing trail.
Comparable ownership Top 5
Janus Henderson Group Ltd. 12%
Farallon Capital Partners, L.P. 9.8%
FARALLON CAPITAL MANAGEMENT, L.L.C. 8.3%
BlackRock, Inc. 7.8%
Ph.D. Jay R. Luly 7.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Janus Henderson Group Ltd.
13F 13D/G
Company · JANUS HENDERSON GROUP PLC
12%
from 13D/G
$47,716,934
3,784,055 shares
31 Mar 2026
Farallon Capital Partners, L.P.
13D/G
Dapice Joshua J.
9.8%
$44,421,914
2,816,862 shares
+$11,174,622 31 Dec 2025
FARALLON CAPITAL MANAGEMENT, L.L.C.
13F 13D/G
Company
8.3%
from 13D/G
$36,271,617
2,871,862 shares
31 Mar 2026
BlackRock, Inc.
13F 13D/G
Company
7.8%
from 13D/G
$39,200,591
3,103,768 shares
31 Mar 2026
Ph.D. Jay R. Luly
3/4/5 13D/G
President and CEO, Director · Jay R. Luly, Ph.D.
7.7%
from 13D/G
$12,424,161
1,181,871 shares
mixed-class rows
-$67,493 12 Feb 2026
Deep Track Capital, LP
13F 13D/G
Company
5%
from 13D/G
$24,715,230
1,956,867 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
120
Shares
27,254,289
Rows available
120
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
132
Q2 2026 holders
120
Holder diff
-12
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .